Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 14.90
-0.88 (-5.58%)
Aug 24, 2026, 3:00 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 8.57 billion as of August 24, 2026. Its market cap has decreased by -32.92% in one year.
Market Cap
8.57B
Enterprise Value
5.89B
Revenue
1.60B
Ranking
n/a
PE Ratio
56.70
Stock Price
14.90
ChartMarket Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 8.57B, a decrease of -81.55%. That is a compound annual growth rate of -24.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 8.57B | -21.11% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Micro-Tech (Nanjing) Co.,Ltd | 13.83B |
| Tofflon Science and Technology Group | 10.98B |
| Qingdao NovelBeam Technology | 10.87B |
| Autek China | 9.85B |
| Eyebright Medical Technology (Beijing) | 7.83B |
| Aidite (Qinhuangdao) Technology | 7.66B |
| Tinavi Medical Technologies | 7.18B |
| Truking Technology | 6.44B |